作者
Armen Yuri Gasparyan, Lilit Ayvazyan, Dimitri P Mikhailidis, George D Kitas
发表日期
2011/1/1
来源
Current pharmaceutical design
卷号
17
期号
1
页码范围
47-58
出版商
Bentham Science Publishers
简介
Platelet activation is a link in the pathophysiology of diseases prone to thrombosis and inflammation. Numerous platelet markers, including mean platelet volume (MPV), have been investigated in connection with both thrombosis and inflammation. This review considers MPV as a prognostic and therapeutic marker as well as the factors influencing its measurement. Established cardiovascular risk factors, such as smoking, hypertension, dyslipidemia, and diabetes, can influence MPV, depending on confounding factors. Low-grade inflammation is one such factor. Evidence, particularly derived from prospective studies and a meta-analysis, suggest a correlation between an increase in MPV and the risk of thrombosis. High MPV associates with a variety of established risk factors, cardio- and cerebrovascular disorders, and low-grade inflammatory conditions prone to arterial and venous thromboses. High-grade …
引用总数
2011201220132014201520162017201820192020202120222023202415389813616717513116619316212311710740
学术搜索中的文章
A Yuri Gasparyan, L Ayvazyan, DP Mikhailidis… - Current pharmaceutical design, 2011